Toba Eye Drops
Developed to mitigate superficial ocular bacterial pathogens to support eye membrane safety and target bacterial protein synthesis.
- Category
- Eye Care
- Active ingredient
- Tobramycin
- Route
- Ocular use
- Form
- Ophthalmic Solution
- Strengths
- 0.3% 5ml
Prescription and consultation requirements for Toba Eye Drops vary by destination and are determined by the fulfilment partner.
Toba Eye Drops details
- Condition
- Superficial Ocular Infections
- Alternative names
- tobramycin
- Therapeutic class
- Aminoglycoside Antibiotic
- Pharmacological class
- Ophthalmic Antibacterial
- Contraindications
- hypersensitivity to tobramycin or other aminoglycosides
- Minor side effects
- mild eye irritation; stinging; lacrimation
- Moderate side effects
- conjunctival redness; eyelid itching; blurred vision
- Serious side effects
- severe corneal toxicity, requires immediate medical attention
- Dosage forms
- Ophthalmic Solution
- Administration route
- Ocular use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Sun Pharmaceutical Industries Ltd
- Onset Time
- 24 hours
- Duration
- 6–8 hours
- Storage instructions
- Store below 25°C. Do not freeze.
- Age restrictions
- Approved for infants over two months, children, and adults.
- Pregnancy and breastfeeding
- TGA Category B: Safe for topical ophthalmic use. Breastfeeding: Compatible.
Patient summary
developed to mitigate superficial ocular bacterial pathogens to support eye membrane safety and target bacterial protein synthesis.
Mechanism of action
Blocks ribosomal translation inside gram-negative bacterial pathogens, leading to bacterial cell membrane death.